Medicines Related Content
New research says remdesivir could be used to treat COVID-19
There is more positive news regarding remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19.
No lockdown: Sweden now faces increased COVID-19 deaths
Researchers explore the results of no lockdown in Sweden, with analysis on how other measures helped the country have less initial deaths.
Signs of being prone to adult diabetes are already visible at age 8
A new study has shown that early signs of being prone to adult diabetes can be seen in children as young as 8 years old, decades before it is likely to be diagnosed.
EUMCA: Limit of 0.2% THC in CBD products should not change
Chair of the European Medicinal Cannabis Association (EUMCA) issues warning that raising limit for THC in CBD to 0.3% will risk patient safety.
The EUMCA: Pioneering access to medicinal cannabis
Professor Trevor Jones, Chair at the European Medicinal Cannabis Association, speaks to Nishat about their plans for EU patient access to medicinal cannabis.
Type 2 diabetes and heart failure creates highest death risk
Those newly diagnosed with Type 2 diabetes and heart failure are at the greatest 5-year risk of death, according to scientists at The American Heart Association.
Attracting major investors: GreenLight on the international stage
In the last six months GreenLight Medicines has successfully out-licenced leads from its research, branching out internationally and attracting major investors.
COVID-19: Maintaining quality control in testing times
With the onset of the COVID-19 pandemic, UKAS highlights the importance of maintaining quality control in testing times.
COVID-19: The time for mental healthcare reform is now
Jennifer Oroilidis and Marie Fallon-Kund, from Mental Health Europe, argue that in light of COVID-19, the time for mental healthcare reform is now.
The silence before the tsunami: COVID is devastating behind NHS virus frontlines
Doctor Allon Barsam, consultant eye surgeon and founder of Ophthalmic Consultants of London, calls attention to the unexplored devastation behind the NHS virus frontlines.
Japan and EU work on strategic partnership for COVID-19 pandemic
President von der Leyen, Council President Charles Michel and Prime Minister of Japan Shinzō Abe, discussed the global response to the COVID-19 pandemic.
Turkey and COVID-19: Success, turmoil, insecurity and opportunity
Dr Ahmet Erdi Öztürk, expert on Turkish politics, discusses the ongoing realities of Turkey and COVID-19.
Existing drugs should be used to treat COVID-19 instead of vaccine
Researchers say we should repurpose existing drugs, which would be faster than waiting for a "magic bullet" vaccine to treat COVID-19.
It should never have taken COVID-19 for us to value rapid testing
Daniel Berman, Head of Global Health, Nesta Challenges, says that it should not have taken COVID-19 to emphasise the necessity of rapid testing.
PMQ’s summary: The NHS, PPE acquisition and knife crime
On 29 April, First Secretary Dominic Raab discussed government plans in relation to crucial issues such as PPE acquisition and knife crime.
The science behind the Hong Kong COVID-19 strategy
Currently, the country has only experienced four deaths: What is the Hong Kong COVID-19 strategy and why is it working so well?
Will tech democratise access to quality healthcare?
Neil Ballinger, head of EMEA sales at EU Automation, explains how greater access to quality healthcare can come from medical data and AI.
Growing pains: Creating value in the maturing cannabis market
Liam McGreevy, CEO of Ethnopharm Ltd, explains his thoughts on creating value in today’s maturing cannabis market, including how the firm can help both new and established businesses make sense of this.
Economic and scientific experts discuss EU response to COVID-19
Here we summarise a discussion with experts on the EU response to COVID-19 and the role of Horizon Europe in this pandemic.
Researchers test drug that stops early stages of COVID-19
Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.